AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
EWTX Edgewise Therapeutics
- 23.610
- -0.210-0.88%
Close Mar 21 16:00 ET
- 23.485
- -0.125-0.53%
Post 18:20 ET
2.25BMarket Cap-16.28P/E (TTM)
24.170High23.230Low1.78MVolume23.605Open23.820Pre Close42.30MTurnover3.28%Turnover RatioLossP/E (Static)95.21MShares38.12052wk High4.90P/B1.28BFloat Cap14.90052wk Low--Dividend TTM54.42MShs Float40.490Historical High--Div YieldTTM3.95%Amplitude5.120Historical Low23.698Avg Price1Lot Size
Edgewise Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.58%-109.03M | -0.47%-26.96M | -24.10%-27.37M | -28.99%-26.1M | -25.29%-28.6M | -74.69%-91.95M | -126.32%-26.83M | -84.39%-22.06M | -24.56%-20.23M | -81.56%-22.83M |
| Net income from continuing operations | -33.60%-133.81M | -31.58%-39.66M | -32.73%-34.13M | -46.71%-31.5M | -24.90%-28.53M | -48.08%-100.16M | -55.26%-30.14M | -46.95%-25.71M | -33.62%-21.47M | -55.78%-22.84M |
| Depreciation and amortization | 32.22%2.29M | 18.01%629K | 21.13%602K | 15.84%534K | 117.84%525K | 221.93%1.73M | 479.35%533K | 201.21%497K | 199.35%461K | 89.76%241K |
| Change In working capital | 762.05%10.33M | 3,553.23%6.94M | 158.01%2.51M | 1,033.63%3.19M | -16.47%-2.32M | -138.18%-1.56M | -103.66%-201K | -52.95%974K | 87.72%-342K | -189.81%-1.99M |
| -Change in prepaid assets | 192.65%3.29M | 518.73%1.59M | 168.37%791K | 158.93%977K | 82.45%-63K | -144.70%-3.55M | -235.84%-379K | -508.95%-1.16M | 14.49%-1.66M | -190.20%-359K |
| -Change in payables and accrued expense | 246.02%7.26M | 1,615.25%5.06M | -14.91%1.9M | 81.38%2.39M | -19.68%-2.09M | -19.90%2.1M | -91.40%295K | 88.68%2.23M | 248.20%1.32M | -57.62%-1.75M |
| -Change in other current liabilities | -111.54%-220K | 351.28%294K | -73.79%-179K | ---171K | -241.38%-164K | -103.56%-104K | -106.58%-117K | -109.57%-103K | --0 | 383.33%116K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.58%-109.03M | -0.47%-26.96M | -24.10%-27.37M | -28.99%-26.1M | -25.29%-28.6M | -74.69%-91.95M | -126.32%-26.83M | -84.39%-22.06M | -24.56%-20.23M | -81.56%-22.83M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -279.48%-184.66M | -22.46%20.92M | 8.30%25.36M | 985.65%37.37M | -647.10%-268.31M | 245.78%102.89M | 135.69%26.98M | 188.97%23.42M | 7,582.61%3.44M | 56.25%49.04M |
| Net PPE purchase and sale | 77.16%-1.31M | -70.19%-274K | -13.79%-520K | 70.88%-221K | 93.20%-297K | -3.59%-5.75M | 95.11%-161K | 65.64%-457K | -37.00%-759K | -1,083.74%-4.37M |
| Net investment purchase and sale | -268.78%-183.34M | -21.91%21.2M | 8.40%25.88M | 794.76%37.59M | -601.80%-268.01M | 267.04%108.63M | 137.54%27.14M | 195.54%23.88M | 726.97%4.2M | 68.19%53.41M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -279.48%-184.66M | -22.46%20.92M | 8.30%25.36M | 985.65%37.37M | -647.10%-268.31M | 245.78%102.89M | 135.69%26.98M | 188.97%23.42M | 7,582.61%3.44M | 56.25%49.04M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 368.82%249.25M | -94.54%2.9M | 1,679.62%3.33M | 429.00%1.95M | 1,147,866.67%241.07M | -58.99%53.17M | 17,587.46%52.99M | -100.16%-211K | 106.15%369K | -71.23%21K |
| Net common stock issuance | 354.50%239.15M | --0 | --0 | --0 | --239.15M | -59.26%52.62M | 9,580.72%52.62M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 1,354.14%10.37M | 804.69%2.9M | 118,133.33%3.55M | 442.01%2M | 9,071.43%1.93M | -1.66%713K | 91.62%320K | -94.23%3K | -14.78%369K | -71.23%21K |
| Net other financing activities | -58.79%-262K | --0 | ---214K | ---- | ---- | 34.26%-165K | -42.35%49K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 368.82%249.25M | -94.54%2.9M | 1,679.62%3.33M | 429.00%1.95M | 1,147,866.67%241.07M | -58.99%53.17M | 17,587.46%52.99M | -100.16%-211K | 106.15%369K | -71.23%21K |
| Net cash flow | ||||||||||
| Beginning cash position | 291.47%86.1M | 35.95%44.81M | 36.72%43.49M | -37.25%30.26M | 291.47%86.1M | 41.29%21.99M | -69.97%32.96M | 73.42%31.81M | 39.99%48.23M | 41.29%21.99M |
| Current changes in cash | -169.31%-44.43M | -105.91%-3.14M | 14.87%1.32M | 180.50%13.22M | -312.80%-55.83M | 897.42%64.1M | 160.56%53.14M | -98.74%1.15M | -1.93%-16.42M | 38.92%26.24M |
| End cash Position | -51.61%41.67M | -51.61%41.67M | 35.95%44.81M | 36.72%43.49M | -37.25%30.26M | 291.47%86.1M | 291.47%86.1M | -69.97%32.96M | 73.42%31.81M | 39.99%48.23M |
| Free cash flow | -12.95%-110.34M | -0.89%-27.23M | -23.89%-27.89M | -25.38%-26.32M | -6.26%-28.9M | -67.91%-97.69M | -78.18%-26.99M | -69.37%-22.52M | -24.97%-20.99M | -110.14%-27.19M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |